Cargando…

Multiple drugs: SARS-CoV-2 pneumonia and off-label use

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532494/ http://dx.doi.org/10.1007/s40278-021-04340-0

Ejemplares similares

Multiple drugs: Persistent SARS-CoV-2 viral load, prolonged or complicated COVID-19 pneumonia and off label use: case report
Publicado: (2022)

Multiple drugs: Reactivation of SARS-CoV-2 infection, vaccine failure and off label use: case report
Publicado: (2021)

Multiple drugs: Off-label use in coronavirus disease 2019 and increase in the viral replication of SARS-CoV-2: 5 case reports
Publicado: (2021)

Anakinra/convalescent-anti-SARS-CoV-2-plasma/prednisolone: Aggravation of SARS-CoV-2 hepatitis, SARS-CoV-2 viraemia and off-label use: case report
Publicado: (2021)

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
por: Morena, Valentina, et al.
Publicado: (2020)

Convalescent-anti-SARS-CoV-2-plasma/immunosuppressants: SARS-CoV-2 infection, its re-infection and off label use: case report
Publicado: (2021)

Dexamethasone/prednisone/rituximab: Prolonged SARS-CoV-2 infection and off-label use: case report
Publicado: (2022)

Multiple drugs: COVID-19-pneumonia, off-label use and lack of efficacy: 2 case reports
Publicado: (2021)

Methylprednisolone: Worsening of SARS-CoV-2 infection during off-label treatment: case report
Publicado: (2020)

Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy in COVID-19 pneumonia and off label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, off-label use and lack of efficacy: case report
Publicado: (2021)

Remdesivir: Rebound effect in the form of SARS-CoV-2 infection following off label use: 2 case reports
Publicado: (2022)

Multiple drugs: Pneumocystis jirovecii pneumonia following off label use and hypersensitivity: case report
Publicado: (2022)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Convalescent anti SARS-CoV-2 plasma/norepinephrine/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2021)

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/remdesivir: Treatment failure and off-label use: case report
Publicado: (2021)

Blinatumomab/convalescent-anti-SARS-CoV-2-plasma: B-cell depletion and off label use: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Antivirals/convalescent-anti-SARS-CoV-2-plasma/imatinib: Haematological disorder and off label use: case report
Publicado: (2021)

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma: Febrile TACO reaction following off-label use: case report
Publicado: (2022)

Multiple drugs: Thrombocytopenia and off-label use: 2 case reports
Publicado: (2021)

Multiple drugs: No response and off-label use: 2 case report
Publicado: (2021)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

Multiple drugs: Lack off efficacy following off-label use: 2 case reports
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Transfusion reaction during off-label therapy: case report
Publicado: (2021)

Anakinra\Convalescent-anti-SARS-CoV-2-plasma\dexamethasone: Pulmonary Aspergillosis and off label use: 6 case reports
Publicado: (2021)

Immune-globulin/methylprednisolone/tocilizumab: Lack of response following off-label use in SARS-CoV-2 infection: case report
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/enoxaparin-sodium/methylprednisolone: Various toxicities and off label use: case report
Publicado: (2021)

Remdesivir/methylprednisolone/convalescent-anti-SARS-CoV-2-plasma: Elevated aminotransferase levels and off-label use: case report
Publicado: (2021)

Azithromycin/convalescent-anti-SARS-CoV-2-plasma/steroids: Necrotising pancreatitis following off label use: case report
Publicado: (2022)

Multiple drugs: Drugs ineffective and off-label use: case report
Publicado: (2022)

SARS-CoV-2 infection with pneumonia and encephalitis
por: Hassan, Muhammad, et al.
Publicado: (2021)

SARS-CoV-2 infection with pneumonia and stroke
por: Hassan, Muhammad, et al.
Publicado: (2021)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Multiple drugs: No response and off label use: case report
Publicado: (2021)

Multiple drugs: No response and off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_inm2539tmeauk9ir3p85iimdsf